Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Tree rings reveal increased fire risk for southwestern US.

Carswell C.

Nature. 2018 Feb 15;554(7692):283-284. doi: 10.1038/d41586-018-01686-y. No abstract available.

PMID:
29446396
2.

Unique oil spill in East China Sea frustrates scientists.

Carswell C.

Nature. 2018 Feb 1;554(7690):17-18. doi: 10.1038/d41586-018-00976-9. No abstract available.

PMID:
29388976
3.

Archaeologists uneasy as Trump shrinks Bears Ears monument lands.

Carswell C.

Nature. 2017 Dec 7;552(7683):13-14. doi: 10.1038/d41586-017-07794-5. No abstract available.

PMID:
29220010
4.

Clinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patients.

Carswell CJ, Win Z, Muckle K, Kennedy A, Waldman A, Dawe G, Barwick TD, Khan S, Malhotra PA, Perry RJ.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):294-299. doi: 10.1136/jnnp-2017-316194. Epub 2017 Oct 10.

5.

Critics pan wolf plan.

Carswell C.

Science. 2017 Sep 29;357(6358):1341-1342. doi: 10.1126/science.357.6358.1341. Epub 2017 Sep 28. No abstract available.

PMID:
28963236
6.

Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease.

Mead S, Burnell M, Lowe J, Thompson A, Lukic A, Porter MC, Carswell C, Kaski D, Kenny J, Mok TH, Bjurstrom N, Franko E, Gorham M, Druyeh R, Wadsworth JD, Jaunmuktane Z, Brandner S, Hyare H, Rudge P, Walker AS, Collinge J.

JAMA Neurol. 2016 Apr;73(4):447-55. doi: 10.1001/jamaneurol.2015.4885.

7.

Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.

Eisenmenger L, Porter MC, Carswell CJ, Thompson A, Mead S, Rudge P, Collinge J, Brandner S, Jäger HR, Hyare H.

JAMA Neurol. 2016 Jan;73(1):76-84. doi: 10.1001/jamaneurol.2015.3159.

8.

Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3.

Battisti WP, Wager E, Baltzer L, Bridges D, Cairns A, Carswell CI, Citrome L, Gurr JA, Mooney LA, Moore BJ, Peña T, Sanes-Miller CH, Veitch K, Woolley KL, Yarker YE; International Society for Medical Publication Professionals.

Ann Intern Med. 2015 Sep 15;163(6):461-4. doi: 10.7326/M15-0288.

PMID:
26259067
9.

Role of the Fourth Transmembrane α Helix in the Allosteric Modulation of Pentameric Ligand-Gated Ion Channels.

Carswell CL, Hénault CM, Murlidaran S, Therien JPD, Juranka PF, Surujballi JA, Brannigan G, Baenziger JE.

Structure. 2015 Sep 1;23(9):1655-1664. doi: 10.1016/j.str.2015.06.020. Epub 2015 Jul 30.

10.

CLIMATE CHANGE. Bumblebees aren't keeping up with a warming planet.

Carswell C.

Science. 2015 Jul 10;349(6244):126-7. doi: 10.1126/science.349.6244.126. No abstract available.

PMID:
26160921
11.

Genome-wide association study of behavioural and psychiatric features in human prion disease.

Thompson AG, Uphill J, Lowe J, Porter MC, Lukic A, Carswell C, Rudge P, MacKay A, Collinge J, Mead S.

Transl Psychiatry. 2015 Apr 21;5:e552. doi: 10.1038/tp.2015.42.

12.

Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration.

Husereau D, Drummond M, Petrou S, Greenberg D, Mauskopf J, Augustovski F, Briggs AH, Moher D, Loder E, Carswell C.

Pharmacoeconomics. 2015 May;33(5):535-6. doi: 10.1007/s40273-015-0277-8. No abstract available.

PMID:
25893576
13.

Atmospheric Science. California fogs are thinning.

Carswell C.

Science. 2015 Mar 13;347(6227):1184-5. doi: 10.1126/science.347.6227.1184. No abstract available.

PMID:
25766210
14.

Down Under: confessions of a vagrant registrar.

Carswell CJ.

Pract Neurol. 2015 Jun;15(3):231-2. doi: 10.1136/practneurol-2014-001041. Epub 2015 Jan 23. No abstract available.

PMID:
25617407
15.

Intramembrane aromatic interactions influence the lipid sensitivities of pentameric ligand-gated ion channels.

Carswell CL, Sun J, Baenziger JE.

J Biol Chem. 2015 Jan 23;290(4):2496-507. doi: 10.1074/jbc.M114.624395. Epub 2014 Dec 17.

16.

The role of the M4 lipid-sensor in the folding, trafficking, and allosteric modulation of nicotinic acetylcholine receptors.

Hénault CM, Sun J, Therien JP, daCosta CJ, Carswell CL, Labriola JM, Juranka PF, Baenziger JE.

Neuropharmacology. 2015 Sep;96(Pt B):157-68. doi: 10.1016/j.neuropharm.2014.11.011. Epub 2014 Nov 26. Review.

PMID:
25433148
17.

Progressive bilateral facial weakness.

Carswell C, Northey LC, Davies L, Yuki N, Kiernan MC.

Pract Neurol. 2015 Feb;15(1):76-9. doi: 10.1136/practneurol-2014-000989. Epub 2014 Oct 29. No abstract available.

18.

Don't blame the beetles.

Carswell C.

Science. 2014 Oct 10;346(6206):154-6. doi: 10.1126/science.346.6206.154. No abstract available.

PMID:
25301598
19.

A novel prion disease associated with diarrhea and autonomic neuropathy.

Mead S, Gandhi S, Beck J, Caine D, Gallujipali D, Carswell C, Hyare H, Joiner S, Ayling H, Lashley T, Linehan JM, Al-Doujaily H, Sharps B, Revesz T, Sandberg MK, Reilly MM, Koltzenburg M, Forbes A, Rudge P, Brandner S, Warren JD, Wadsworth JDF, Wood NW, Holton JL, Collinge J.

N Engl J Med. 2013 Nov 14;369(20):1904-14. doi: 10.1056/NEJMoa1214747. Erratum in: N Engl J Med. 2014 Jan 9;370(2):188. Gallujipali, Dillip [corrected to Gajulapalli, Dilip].

20.

New Zealand's drug development industry.

Lockhart MM, Babar ZU, Carswell C, Garg S.

Int J Environ Res Public Health. 2013 Sep 13;10(9):4339-51. doi: 10.3390/ijerph10094339. Review.

21.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E; CHEERS Task Force.

Int J Technol Assess Health Care. 2013 Apr;29(2):117-22. doi: 10.1017/S0266462313000160. Epub 2013 Apr 15.

PMID:
23587340
22.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E; CHEERS Task Force.

BJOG. 2013 May;120(6):765-70. doi: 10.1111/1471-0528.12241.

23.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E; CHEERS Task Force.

Value Health. 2013 Mar-Apr;16(2):e1-5. doi: 10.1016/j.jval.2013.02.010.

24.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E; ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force.

Value Health. 2013 Mar-Apr;16(2):231-50. doi: 10.1016/j.jval.2013.02.002.

25.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E; CHEERS Task Force.

Clin Ther. 2013 Apr;35(4):356-63. doi: 10.1016/j.clinthera.2013.03.003. Epub 2013 Mar 25.

PMID:
23537754
26.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E; CHEERS Task Force.

Cost Eff Resour Alloc. 2013 Mar 25;11(1):6. doi: 10.1186/1478-7547-11-6.

27.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E; CHEERS Task Force.

BMC Med. 2013 Mar 25;11:80. doi: 10.1186/1741-7015-11-80.

28.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E; CHEERS Task Force.

BMJ. 2013 Mar 25;346:f1049. doi: 10.1136/bmj.f1049.

29.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E.

Pharmacoeconomics. 2013 May;31(5):361-7. doi: 10.1007/s40273-013-0032-y.

PMID:
23529207
30.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E.

Eur J Health Econ. 2013 Jun;14(3):367-72. doi: 10.1007/s10198-013-0471-6.

PMID:
23526140
31.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E; CHEERS Task Force.

J Med Econ. 2013;16(6):713-9. doi: 10.3111/13696998.2013.784591. Epub 2013 Mar 25.

PMID:
23521434
32.

MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease.

Carswell C, Thompson A, Lukic A, Stevens J, Rudge P, Mead S, Collinge J, Hyare H.

BMC Neurol. 2012 Dec 5;12:153. doi: 10.1186/1471-2377-12-153.

33.

A comparison of two experimental design approaches in applying conjoint analysis in patient-centered outcomes research: a randomized trial.

Kinter ET, Prior TJ, Carswell CI, Bridges JF.

Patient. 2012;5(4):279-94. doi: 10.2165/11641100-000000000-00000.

PMID:
23145548
34.

Video Rating in Neurodegenerative Disease Clinical Trials: The Experience of PRION-1.

Carswell C, Rañopa M, Pal S, Macfarlane R, Siddique D, Thomas D, Webb T, Wroe S, Walker S, Darbyshire J, Collinge J, Mead S, Rudge P.

Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):286-97. doi: 10.1159/000339730. Epub 2012 Aug 8.

35.

One-year treatment continuation in patients prescribed risperidone long-acting injection in New Zealand: a retrospective study.

Wheeler A, Vanderpyl J, Carswell C, Stojkovic M, Robinson E.

Clin Schizophr Relat Psychoses. 2012 Jul;6(2):61-8. doi: 10.3371/CSRP.6.2.3.

PMID:
22776632
36.

Explicit review of risperidone long-acting injection prescribing practice.

Wheeler A, Vanderpyl J, Carswell C, Stojkovic M, Robinson E.

J Clin Pharm Ther. 2011 Dec;36(6):651-63. doi: 10.1111/j.1365-2710.2010.01219.x. Epub 2010 Nov 5.

PMID:
22023342
37.

The successful long-term management of an intracranial inflammatory myofibroblastic tumor with corticosteroids.

Carswell C, Chataway J.

Clin Neurol Neurosurg. 2012 Jan;114(1):77-9. doi: 10.1016/j.clineuro.2011.07.026. Epub 2011 Sep 1. No abstract available.

PMID:
21889257
38.

Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis.

Carswell C, Wheeler A, Vanderpyl J, Robinson E.

Clin Drug Investig. 2010;30(11):777-87. doi: 10.2165/11537680-000000000-00000.

PMID:
20712387
39.

Hands-free administration of subjective workload scales: acceptability in a surgical training environment.

Carswell CM, Lio CH, Grant R, Klein MI, Clarke D, Seales WB, Strup S.

Appl Ergon. 2010 Dec;42(1):138-45. doi: 10.1016/j.apergo.2010.06.003. Epub 2010 Jul 13.

PMID:
20630495
40.

Anionic lipids allosterically modulate multiple nicotinic acetylcholine receptor conformational equilibria.

daCosta CJ, Medaglia SA, Lavigne N, Wang S, Carswell CL, Baenziger JE.

J Biol Chem. 2009 Dec 4;284(49):33841-9. doi: 10.1074/jbc.M109.048280. Epub 2009 Oct 8.

41.

Andrew lloyd: a driving force in patient-centered outcomes research.

Bridges JF, Carswell CI.

Patient. 2008 Dec 1;1(4):259-63. doi: 10.2165/01312067-200801040-00007. No abstract available.

PMID:
22272993
42.

Expression, purification, and structural characterization of CfrA, a putative iron transporter from Campylobacter jejuni.

Carswell CL, Rigden MD, Baenziger JE.

J Bacteriol. 2008 Aug;190(16):5650-62. doi: 10.1128/JB.00298-08. Epub 2008 Jun 13.

43.

Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.

Ryan SD, Harris CS, Carswell CL, Baenziger JE, Bennett SA.

J Lipid Res. 2008 Oct;49(10):2250-8. doi: 10.1194/jlr.M800263-JLR200. Epub 2008 Jun 12.

44.

Meandering down the road to transparency.

Carswell CI, Paladino JA.

Pharmacoeconomics. 2008;26(3):179-80. No abstract available.

PMID:
18282012
45.

Honoring pioneers in patient-centered outcomes research.

Bridges JF, Carswell CI.

Patient. 2008 Jan 1;1(1):5-6. No abstract available.

PMID:
22272752
46.

The role of the patient in promoting patient-centered outcomes research.

Klag MJ, Mackenzie EJ, Carswell CI, Bridges JF.

Patient. 2008 Jan 1;1(1):1-3. No abstract available.

PMID:
22272751
47.

Evidence for an elders' advantage in the naive product usability judgments of older and younger adults.

Stephens EC, Carswell CM, Schumacher MM.

Hum Factors. 2006 Fall;48(3):422-33.

PMID:
17063959
48.

Reporting pharmacoeconomic evaluations.

Carswell CI, Paladino JA.

Pharmacoeconomics. 2005;23(11):1073. No abstract available.

PMID:
16277544
49.

Assessing mental workload during laparoscopic surgery.

Carswell CM, Clarke D, Seales WB.

Surg Innov. 2005 Mar;12(1):80-90.

PMID:
15846451
50.

Losartan in diabetic nephropathy.

Carswell CI, Goa KL.

Drugs. 2003;63(4):407-14; discussion 415-6. Review.

PMID:
12558462

Supplemental Content

Loading ...
Support Center